Clinical Trial

Prognostic Value of Novel Biomarkers on Adverse Renal Outcomes in High-Risk Cardiac Surgery Patients

Recruiting
View on ClinicalTrials.gov →
Summary
This project aims to detect novel biomarkers from preoperative and early postoperative serum and urine samples of patients to screen and analyze the risk factors for predicting adverse postoperative renal outcomes in high-risk patients in cardiac surgery.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-05-19
Trial Details
NCT Number NCT07418242
Lead Sponsor Guowei Tu
Conditions Cardiac Surgery Associated - Acute Kidney Injury, Critical Illness
Enrollment 1,491 participants
Start Date 2026-02-23
Primary Completion 2028-12-31 (estimated)
Study Completion 2029-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-18